J+
JOHNSON + JOHNSON
JNJ· Health Care· PharmaceuticalsS&P 500
Close · 13/11/2026
285.75
1D
+0.79%52-week range
193.45 – 288.11
Volume
62,82,000.00
Price history
JNJ
15/10/2026 to 13/11/2026
O 285.00 H 288.11 L 281.68
1W+3.45%
1M+12.82%
3M+8.91%
6M+26.04%
1Y+47.00%
3Y+90.06%
5Y+74.85%
MAX+72.35%
Fundamentals
as of 13/11/2026- Market cap
- $687.89B
- Shares out
- 2.41B
- P/E (trailing)
- 42.74
- P/E (forward)
- 24.59
- EPS (trailing)
- 6.69
- Dividend yield
- 1.85%
- Beta
- 0.20
- Profit margin
- 16.20%
- P/B
- 8.44
- Return on equity
- 19.74%
SEC financial statements
69 quarterly and 19 annual periods through 27/09/2026.
Details
- Ticker
- JNJ
- Index
- SP500
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
51 filers · 4 on watchlist · 94 buys · 71 sells · ?: 27 · R: 69 · D: 69
- 30/09/2026Thomas H. KeanSell+Johnson & Johnson Common Stock$1,001–$15,000
- 08/09/2026Lloyd DoggettBuyJohnson & Johnson Common Stock$1,001–$15,000
- 27/08/2026Thomas H. KeanSell+Johnson & Johnson Common Stock$1,001–$15,000
- 20/08/2026John BoozmanWSell+Johnson & Johnson Common Stock$1,001–$15,000
- 30/07/2026Richard Dean Dr McCormickSellJohnson & Johnson Common Stock$1,001–$15,000
- 29/10/2024Thomas H TubervilleWSellJohnson & Johnson Common Stock$15,001–$50,000
- 29/10/2024Thomas H TubervilleWSellJohnson & Johnson Common Stock$15,001–$50,000
- 30/03/2026Alan ArmstrongBuyJohnson & Johnson Common Stock$1,001–$15,000